×







We sell 100% Genuine & New Books only!

Cost-effectiveness analysis of HIV/AIDS Test and treat strategy vs. Current treatment guideline in Botswana 2015 Edition at Meripustak

Cost-effectiveness analysis of HIV/AIDS Test and treat strategy vs. Current treatment guideline in Botswana 2015 Edition by Geffrey Li, GRIN Publishing

Books from same Author: Geffrey Li

Books from same Publisher: GRIN Publishing

Related Category: Author List / Publisher List


  • Price: ₹ 1424.00/- [ 2.00% off ]

    Seller Price: ₹ 1396.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s) Geffrey Li
    Publisher GRIN Publishing
    ISBN9783656921653
    Pages24
    BindingPaperback
    Language English
    Publish YearMarch 2015

    Description

    GRIN Publishing Cost-effectiveness analysis of HIV/AIDS Test and treat strategy vs. Current treatment guideline in Botswana 2015 Edition by Geffrey Li

    Seminar paper from the year 2015 in the subject Medicine - Other, Johns Hopkins University, language: English, abstract: A more aggressive strategy "test and treat" is predicted to reduce AIDS-related mortality, increase the life expectancy of people living with HIV and is cost-effective. However, the cost-effectiveness studies related to "test and treat" strategy did not consider the possibility of increased drug resistance due to poor adherence, which is not rare in developing countries. There is a need for a cost-effectiveness analysis related to "test and treat" strategy in developing countries that includes drug resistance as an important parameter. This analysis is to support the government of Botswana to examine the cost-effectiveness of a HIV/AIDS "test and treat" strategy vs. current treatment guideline, which is providing treatment to patients with a CD4 count ofshow more



    Book Successfully Added To Your Cart